The 23 analysts offering 12-month price forecasts for Gilead Sciences Inc have a median target of 81.00, with a high estimate of 97.00 and a low estimate of 58.00. The median estimate represents a +6.09% increase from the last price of 76.35.
The current consensus among 30 polled investment analysts is to Hold stock in Gilead Sciences Inc. This rating has held steady since June, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.50
Reporting Date Jul 22
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.